Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence (PSMA BCR)

NCT02918357 PHASE2, PHASE3 COMPLETED Results posted

The investigators are imaging patients with prostate cancer using a new PET imaging agent (Ga-68-PSMA-11) in order to evaluate it's ability to detection prostate cancer in patients with biochemical recurrence after prostatectomy and radiation therapy.

Details

Lead sponsor	University of California, San Francisco
Phase	PHASE2, PHASE3
Status	COMPLETED
Enrolment	385
Start date	Thu Sep 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Sep 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Prostate Cancer

Interventions

• Ga-68 labeled PSMA-11 PET

Countries

United States